Tag:

Cancidas

Latest Headlines

Latest Headlines

Positive Phase II results for fungal infection drug

Merck has unveiled interim Phase II data for Cancidas, an antifungal drug for pediatric patients with candidiasis, esophageal candidiasis or invasive aspergillosis. Seventy-four percent of trial